Literature DB >> 2487542

Trial alert.

L Opie.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2487542     DOI： 10.1007/bf01869562

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  7 in total

1.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

2.  Can the progression of coronary sclerosis be influenced by calcium antagonists?

Authors:  G Kober; W Schneider; M Kaltenbach
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

3.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

4.  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

Authors: 
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

5.  International nifedipine trial on antiatherosclerotic therapy (INTACT).

Authors:  P R Lichtlen; U Nellessen; W Rafflenbeul; S Jost; H Hecker
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

6.  Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

7.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245
  7 in total
  1 in total

1.  Investigation of Metabolite Profile of YM758, a Novel If Channel Inhibitor.

Authors:  Naoyuki Nakada
Journal:  Drugs R D       Date:  2016-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.